This is a short update on several issues. First, CDEX has passed another milestone – in July we received our first “revenues”. The revenue came from the testing contract under the auspices of the U.S. Army announced in my last CEO statement. Under that contract, we are continuing to provide information regarding testing of the EM-1X to the U.S. Army. Pursuant to the contract, we are unable to provide details to the public regarding the testing at this time.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.